Methoxphenidine / MXP / 1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine - is a new in-vitro NMDA antagonist, and is easily approachable to mainstream researchers and is in stock now.
We have Methoxphenidine / MXP in a high quality fine white powder form.
Methoxphenidine (MXP) aka 1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine aka 2-MeO-Diphenidine acts on the dopamine transport as a dopamine reuptake inhibitor and as a selective NMDA receptor antagonist, comparable to other NMDA antagonists, such as Methoxetamine and 4-Meo-PCP. Our Methoxphenidine is certified at the highest grade purity available. This compound needs to be researched with caution.
Since Methoxetamine, and 4-Meo-PCP were banned there has been a void in this area of research, although not a direct replacement of either Chemicals, Methoxphenidine should provide similar results within laboratory experiments.
Methoxphenidine is likely to be popular with Scientists and researchers who have had previous research experience with Methoxetamine.